清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
潜行者完成签到 ,获得积分10
10秒前
由亦非完成签到,获得积分10
10秒前
47秒前
51秒前
Charming完成签到,获得积分10
52秒前
Charming发布了新的文献求助10
57秒前
2分钟前
zsyf发布了新的文献求助10
2分钟前
Kinkin完成签到,获得积分10
2分钟前
DarknessDuck发布了新的文献求助10
2分钟前
纪靖雁完成签到 ,获得积分10
2分钟前
zsyf完成签到,获得积分10
2分钟前
molihuakai应助DarknessDuck采纳,获得10
2分钟前
2分钟前
谢锦印完成签到,获得积分10
3分钟前
3分钟前
谢锦印发布了新的文献求助10
3分钟前
欣欣发布了新的文献求助10
3分钟前
mzhang2完成签到 ,获得积分10
3分钟前
玩命的寄翠完成签到 ,获得积分10
3分钟前
勤劳觅风完成签到,获得积分10
3分钟前
儒雅的夏翠完成签到,获得积分10
3分钟前
呆萌如容完成签到,获得积分10
3分钟前
科研通AI2S应助铭铭采纳,获得10
5分钟前
胡萝卜完成签到,获得积分10
5分钟前
5分钟前
铭铭发布了新的文献求助10
5分钟前
香蕉觅云应助铭铭采纳,获得10
5分钟前
标致的满天完成签到 ,获得积分10
5分钟前
Phiephie发布了新的文献求助10
6分钟前
6分钟前
铭铭发布了新的文献求助10
6分钟前
机灵自中完成签到,获得积分10
6分钟前
Seriously完成签到,获得积分10
6分钟前
FashionBoy应助铭铭采纳,获得10
7分钟前
欣喜的香菱完成签到 ,获得积分10
7分钟前
Cm666应助Xenomorph采纳,获得10
7分钟前
桐桐应助科研通管家采纳,获得10
7分钟前
Orange应助科研通管家采纳,获得10
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics 500
A Social and Cultural History of the Hellenistic World 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6394582
求助须知:如何正确求助?哪些是违规求助? 8209714
关于积分的说明 17382316
捐赠科研通 5447800
什么是DOI,文献DOI怎么找? 2880027
邀请新用户注册赠送积分活动 1856542
关于科研通互助平台的介绍 1699160